Clinical Pharmacology and Toxicology Institute, University Hospital Friuli Centrale ASUFC, Udine, Italy.
Department of Medicine (DMED), University of Udine (UNIUD), Udine, Italy.
Clin Infect Dis. 2024 Sep 26;79(3):596-599. doi: 10.1093/cid/ciae178.
Precision daptomycin dosing faces clinical implementation barriers despite known exposure-safety concerns with the use of twice the regulatory-approved doses. We propose achieving a single 7-11-hour post-dose plasma target concentration of 30 mg/L to 43 mg/L to be a practical starting point to facilitate precision daptomycin dosing.
尽管已知使用两倍监管批准剂量存在暴露安全性问题,但精准达托霉素给药仍面临临床实施障碍。我们建议将单次给药后 7-11 小时的血浆靶浓度达到 30-43mg/L 作为精准达托霉素给药的一个实用起点。